By Rob Wright, Chief Editor, Life Science Leader magazine
Trevena is a clinical-stage, drug discovery and development company founded in 2008. Its founding President and CEO, Maxine Gowen, Ph.D., has previously held a variety of leadership roles, including serving as an SVP for GSK’s Center of Excellence for External Drug Discovery (CEEDD). There she developed an innovative new approach to externalizing drug discovery in big pharma. In her current role, Gowen is intricately involved in the selection and vendor partnering process, including developing strategic partnerships with CROs. Below are her executive insights in response to questions posed by Life Science Leader on the how she approaches the CRO vetting process.